Status:
TERMINATED
Role of Blood Management in Perioperative Outcomes
Lead Sponsor:
The Cleveland Clinic
Conditions:
Abnormal Uterine Bleeding
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
There is currently limited information regarding the role of blood management in the benign gynecologic population and specifically, in patients who are scheduled to undergo surgery for fibroids and/o...
Detailed Description
Title : Role of blood management in optimizing perioperative outcomes in patients with secondary anemia undergoing hysterectomy or myomectomy for abnormal uterine bleeding: A Proposed Randomized Contr...
Eligibility Criteria
Inclusion
- Anemic patients (defined as Hgb \< 11g/dL within 30 days of initial consult visit)
- Greater than 18-years of age with abnormal uterine bleeding or fibroids
- Scheduled for gynecologic surgery (myomectomy or hysterectomy by laparoscopic, robotic, vaginal or open routes)
Exclusion
- Malignancy
- Pregnancy
- Sickle cell anemia or other blood dyscrasias
- Women who received blood transfusions within 30 days prior to surgery
- Women receiving EPO therapy
- Women who have undergone gastric bypass surgery
- Women on therapeutic/full anticoagulation
- Patients undergoing hysteroscopic myomectomy alone without will not be included in the study
Key Trial Info
Start Date :
July 24 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 18 2023
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT04475497
Start Date
July 24 2020
End Date
May 18 2023
Last Update
September 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic
Cleveland, Ohio, United States, 44195